Hikma Pharmaceuticals PLC
HIK
ISIN GB00B0LCW083 / Valor 2324471
Hikma Pharmaceuticals PLC
UMushroom community rating:
About company
Hikma Pharmaceuticals PLC is a London‑listed pharmaceutical company, founded in Jordan and headquartered in London, that develops, manufactures and commercialises a broad range of branded and generic medicines across the United States, the Middle East & North Africa and Europe. Its core operations cover three main areas—injectable medicines (including sterile hospital injectables), generic oral medicines and branded generics for regional markets—supplied through its own manufacturing sites and commercial networks to hospitals, wholesalers and retail pharmacies. The company combines in‑house development and manufacturing with licensing and partnerships to bring off‑patent and complex generic products to market, with a particular emphasis on injectable and hospital-use therapies.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
3715 M
Market cap (USD)
560,420
Daily traded volume (Shares)
19.9 / 19.68
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Moska Ahmadzai
Brooklyn Fu
Francesco Cuviello
EQUITIES OF THE SAME SECTOR
